Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture.

BACKGROUND In the short- to mid-term, cardiomyocytes generated from human-induced pluripotent stem cells (hiPSC-CMs) have been reported to be less mature than those of adult hearts. However, the maturation process in a long-term culture remains unknown. METHODS AND RESULTS A hiPSC clone generated from a healthy control was differentiated into CMs through embryoid body (EB) formation. The ultrastructural characteristics and gene expressions of spontaneously contracting EBs were analyzed through 1-year of culture after cardiac differentiation was initiated. The 14-day-old EBs contained a low number of myofibrils, which lacked alignment, and immature high-density Z-bands lacking A-, H-, I-, and M-bands. Through the long-term culture up to 180 days, the myofibrils became more tightly packed and formed parallel arrays accompanied by the appearance of mature Z-, A-, H-, and I-bands, but not M-bands. Notably, M-bands were finally detected in 360-day-old EBs. The expression levels of the M-band-specific genes in hiPSC-CMs remained lower in comparison with those in the adult heart. Immunocytochemistry indicated increasing number of MLC2v-positive/MLC2a-negative cells with decreasing number of MLC2v/MLC2a double-positive cells, indicating maturing of ventricular-type CMs. CONCLUSIONS The structural maturation process of hiPSC-CMs through 1-year of culture revealed ultrastructural sarcomeric changes accompanied by delayed formation of M-bands. Our study provides new insight into the maturation process of hiPSC-CMs. 

[1]  Christine L Mummery,et al.  Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. , 2012, Circulation research.

[2]  Gary R. Mirams,et al.  Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG. , 2012, Journal of molecular and cellular cardiology.

[3]  Ofer Binah,et al.  Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation , 2012, Journal of cellular and molecular medicine.

[4]  Rui Chen,et al.  Three‐dimensional co‐culture facilitates the differentiation of embryonic stem cells into mature cardiomyocytes , 2011, Journal of cellular biochemistry.

[5]  James A Thomson,et al.  High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. , 2011, American journal of physiology. Heart and circulatory physiology.

[6]  Gordon Keller,et al.  SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells , 2011, Nature Biotechnology.

[7]  Ofer Binah,et al.  Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure , 2011, Journal of cellular and molecular medicine.

[8]  Halina Dobrzynski,et al.  Changes in the expression of ion channels, connexins and Ca2+‐handling proteins in the sino‐atrial node during postnatal development , 2011, Experimental physiology.

[9]  Hideki Uosaki,et al.  Induction and Enhancement of Cardiac Cell Differentiation from Mouse and Human Induced Pluripotent Stem Cells with Cyclosporin-A , 2011, PloS one.

[10]  W. Rottbauer,et al.  Myomasp/LRRC39, a Heart- and Muscle-Specific Protein, Is a Novel Component of the Sarcomeric M-Band and Is Involved in Stretch Sensing , 2010, Circulation research.

[11]  Karl-Ludwig Laugwitz,et al.  Patient-specific induced pluripotent stem-cell models for long-QT syndrome. , 2010, New England Journal of Medicine.

[12]  Marius Wernig,et al.  Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  Huei-Sheng Vincent Chen,et al.  Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation. , 2010, Stem cells and development.

[14]  J. Itskovitz‐Eldor,et al.  Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells , 2009, Journal of cellular and molecular medicine.

[15]  R. Jaenisch,et al.  Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  Gregory T. A. Kovacs,et al.  Current-Controlled Electrical Point-Source Stimulation of Embryonic Stem Cells , 2009, Cellular and molecular bioengineering.

[17]  LimorZwi,et al.  Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells , 2009 .

[18]  Lior Gepstein,et al.  Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells , 2009, Circulation.

[19]  T. Ichisaka,et al.  Hypoxia enhances the generation of induced pluripotent stem cells. , 2009, Cell stem cell.

[20]  Sean P. Palecek,et al.  Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.

[21]  Eric D. Adler,et al.  Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population , 2008, Nature.

[22]  H. Baharvand,et al.  Ultrastructural comparison of developing mouse embryonic stem cell‐ and in vivo‐derived cardiomyocytes , 2006, Cell biology international.

[23]  Irina Agarkova,et al.  The M-band: an elastic web that crosslinks thick filaments in the center of the sarcomere. , 2005, Trends in cell biology.

[24]  Hossein Baharvand,et al.  The effect of extracellular matrix on embryonic stem cell-derived cardiomyocytes. , 2005, Journal of molecular and cellular cardiology.

[25]  J. Itskovitz‐Eldor,et al.  Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. , 2003, American journal of physiology. Heart and circulatory physiology.

[26]  James A Thomson,et al.  Human Embryonic Stem Cells Develop Into Multiple Types of Cardiac Myocytes: Action Potential Characterization , 2003, Circulation research.

[27]  K. Chien,et al.  Chamber specification of atrial myosin light chain-2 expression precedes septation during murine cardiogenesis. , 1994, The Journal of biological chemistry.

[28]  J. Schaper,et al.  Human fetal heart development after mid-term: morphometry and ultrastructural study. , 1992, Journal of molecular and cellular cardiology.

[29]  P. Anversa,et al.  Postnatal Development of the M‐Band in Rat Cardiac Myofibrils , 1981, Circulation research.

[30]  M. Legato,et al.  Sarcomerogenesis in human myocardium. , 1970, Journal of molecular and cellular cardiology.

[31]  S. Baek,et al.  Perspectives on stem cell therapy for cardiac regeneration. Advances and challenges. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[32]  田中 智文,et al.  In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes , 2012 .

[33]  J. Hescheler,et al.  Molecular and functional changes in voltage-gated Na⁺ channels in cardiomyocytes during mouse embryogenesis. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[34]  B. Thiers Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .

[35]  D. Tucker,et al.  Morphological development of the rat heart growing in oculo in the absence of hemodynamic work load. , 1990, Circulation research.